2 July 2026
Latham Advises on Abivax’s Oversubscribed and Upsized US$800 Million Public Offering of American Depositary Shares
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Alison Haggerty Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Sandy Kugbei Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Isabelle Sawhney | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Kan Ni | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 800m (US$800 Million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Abivax SA (Issuer)